Guidance for Industry No 152
This FDA guidance discusses a recommended approach for assessing the safety of antimicrobial new animal drugs with regard to their microbiological effects on bacteria of human health concern.
GFI152 (pdf, 290 KB)
Posted on March 7, 2016